These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. Granja F; Morari J; Morari EC; Correa LA; Assumpção LV; Ward LS Cancer Lett; 2004 Jul; 210(2):151-7. PubMed ID: 15183530 [TBL] [Abstract][Full Text] [Related]
4. TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3. Jha P; Jha P; Pathak P; Chosdol K; Suri V; Sharma MC; Kumar G; Singh M; Mahapatra AK; Sarkar C Exp Mol Pathol; 2011 Apr; 90(2):167-72. PubMed ID: 21115003 [TBL] [Abstract][Full Text] [Related]
5. TP53 codon 72 polymorphism in oral squamous cell carcinoma. Drummond SN; De Marco L; Pordeus Ide A; Barbosa AA; Gomez RS Anticancer Res; 2002; 22(6A):3379-81. PubMed ID: 12530090 [TBL] [Abstract][Full Text] [Related]
6. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck. Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666 [TBL] [Abstract][Full Text] [Related]
7. [TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela]. Cañas M; Morán Y; Camargo ME; Rivero MB; Bohórquez A; Villegas V; Ramírez E; Rendón Y; Suárez A; Morales L; Useche E; Salazar S; Zambrano A; Ramírez A; Valderrama E; Briceño Z; Chiurillo MA Invest Clin; 2009 Jun; 50(2):153-61. PubMed ID: 19662811 [TBL] [Abstract][Full Text] [Related]
8. Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia. Hadhri-Guiga B; Toumi N; Khabir A; Sellami-Boudawara T; Ghorbel A; Daoud J; Frikha M; Gargouri A; Mokdad-Gargouri R Cancer Genet Cytogenet; 2007 Oct; 178(2):89-93. PubMed ID: 17954263 [TBL] [Abstract][Full Text] [Related]
9. Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas. Cortezzi SS; Provazzi PJ; Sobrinho JS; Mann-Prado JC; Reis PM; de Freitas SE; Filho JF; Fukuyama EE; Cordeiro JA; Cury PM; Maniglia JV; Villa LL; Tajara EH; Rahal P Cancer Genet Cytogenet; 2004 Apr; 150(1):44-9. PubMed ID: 15041222 [TBL] [Abstract][Full Text] [Related]
10. Association of TP53 codon 72 polymorphism with susceptibility to ovarian carcinomas in Serbian women. Malisic EJ; Jankovic RN; Jakovljevic KV; Radulovic SS Eur J Obstet Gynecol Reprod Biol; 2013 Jan; 166(1):90-3. PubMed ID: 23092908 [TBL] [Abstract][Full Text] [Related]
11. Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility. To-Figueras J; Gene M; Gomez-Catalan J; Galan C; Firvida J; Fuentes M; Rodamilans M; Huguet E; Estape J; Corbella J Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):337-42. PubMed ID: 9162298 [TBL] [Abstract][Full Text] [Related]
12. Germline polymorphism of p53 codon 72 in gynecological cancer. Ueda M; Terai Y; Kanda K; Kanemura M; Takehara M; Yamaguchi H; Nishiyama K; Yasuda M; Ueki M Gynecol Oncol; 2006 Jan; 100(1):173-8. PubMed ID: 16168468 [TBL] [Abstract][Full Text] [Related]
13. The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death. Bonafé M; Salvioli S; Barbi C; Trapassi C; Tocco F; Storci G; Invidia L; Vannini I; Rossi M; Marzi E; Mishto M; Capri M; Olivieri F; Antonicelli R; Memo M; Uberti D; Nacmias B; Sorbi S; Monti D; Franceschi C Cell Death Differ; 2004 Sep; 11(9):962-73. PubMed ID: 15131588 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the frequency of TP53 gene codon 72 polymorphisms in Iranian patients with endometrial cancer. Ghasemi N; Karimi-Zarchi M; Mortazavi-Zadeh MR; Atash-Afza A Cancer Genet Cytogenet; 2010 Jan; 196(2):167-70. PubMed ID: 20082853 [TBL] [Abstract][Full Text] [Related]
15. Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk. Damin AP; Frazzon AP; Damin DC; Roehe A; Hermes V; Zettler C; Alexandre CO Cancer Detect Prev; 2006; 30(6):523-9. PubMed ID: 17113725 [TBL] [Abstract][Full Text] [Related]
16. Association between TP53 gene ARG72PRO polymorphism and chromosome aberrations in human cancers. Litviakov NV; Denisov EV; Takhauov RM; Karpov AB; Skobel'skaja EV; Vasil'eva EO; Goncharik OO; Ageeva AM; Mamonova NV; Mezheritskiy SA; Sevost'janova NV; Koshel AP Mol Carcinog; 2010 Jun; 49(6):521-4. PubMed ID: 20512840 [TBL] [Abstract][Full Text] [Related]
17. TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin. Kim JG; Sohn SK; Chae YS; Song HS; Kwon KY; Do YR; Kim MK; Lee KH; Hyun MS; Lee WS; Sohn CH; Jung JS; Kim GC; Chung HY; Yu W Cancer Chemother Pharmacol; 2009 Jul; 64(2):355-60. PubMed ID: 19052714 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of P(53) and bcl-2 in benign and malignant salivary glands tumors. Al-Rawi NH; Omer H; Al Kawas S J Oral Pathol Med; 2010 Jan; 39(1):48-55. PubMed ID: 19761475 [TBL] [Abstract][Full Text] [Related]
19. Fas single nucleotide polymorphisms and risk of thyroid and salivary gland carcinomas: a case-control analysis. Ho T; Li G; Zhao C; Zheng R; Wei Q; Sturgis EM Head Neck; 2008 Mar; 30(3):297-305. PubMed ID: 17657791 [TBL] [Abstract][Full Text] [Related]
20. Implications of methylation patterns of cancer genes in salivary gland tumors. Williams MD; Chakravarti N; Kies MS; Maruya S; Myers JN; Haviland JC; Weber RS; Lotan R; El-Naggar AK Clin Cancer Res; 2006 Dec; 12(24):7353-8. PubMed ID: 17189407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]